CRISPR-edited CAR T Cells Enhance Fight Against Blood Cancers

CRISPR-edited CAR T Cells Enhance Fight Against Blood Cancers
John Amis/AP Images for Macy's

Knocking out a protein known to stifle T cell activation on CAR T cells using the CRISPR/Cas9 technology enhanced the engineered T cells’ ability to eliminate blood cancers, according to new preclinical data from researchers in the Perelman School of Medicine at the University of Pennsylvania and Penn’s Abramson Cancer Center.

Read Full Article »


Comment
Show comments Hide Comments


Related Articles